Upregulation of N-acetylaspartic Acid Induces Oxidative Stress to Contribute in Disease Pathophysiology

REFERENCES

• Baslow, M. H. (2000). Functions of N-Acetyl-l-aspartate and N-acetyl-L- aspartylglutamate in the vertebrate brain. Journal of Neurochemistry, 75, 453–459.
   PubMed Web of Science ®Google Scholar
• Bennet, M. J., Gibson, K. M., Sherwood, W. G., Divry, P., Rolland, M. O., (1993). Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): Comparison of enzymatic and metabolite analysis. Journal of Inherited Metabolic Disease, 16, 831–836.
   PubMedGoogle Scholar
• Bhatnagar, M., Sharma, D., & Salvi, M. (2009). Neuroprotective effects of Withania somnifera: A possible mechanism. Journal Neurochemical Research, 34, 1975–1983.
   Google Scholar
• Delaney, B. (2010). Acute oral toxicity of N-acetyl-l-aspartic acid (NAA) in rats. Food and Chemical Toxicology, 48, 1761.
   Google Scholar
• Goldstein, F. B. (1969). The enzymatic synthesis of N-acetyl-L-aspartic acid by subcellular preparations of the rat brain. Journal of Biological Chemistry, 244, 4257–4260.
   PubMedGoogle Scholar
• Hession, A. O., Esrey, E. G., Croes, R. A., & Maxwell, C. A. (2008). N-acetylglutamate and N-acetylaspartate in soybeans (Glycine max L.), maize (Zea maize L.), and other foodstuffs. Journal of Agricultural Food and Chemical, 56, 9121–9126.
   PubMedGoogle Scholar
• Kaya, N., Fimtiaz, F., Colak, D., Al-Sayed, M., Al-Odaib, A., Al-Zahrani, F., (2008). Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease. Genetics in Medicine, 10, 675–684.
   PubMedGoogle Scholar
• Konov, S. (2007). HIV treatment bulletin conference reports. Retrieved on January 14, 2011 from http://www.aegis.com/files/i-base/2007/htbmay07.pdf
   Google Scholar
• Lee, D.-H., & Pfeifer, G. P. (2007). Mutagenesis induced by the nitric oxide donor sodium nitroprusside in mouse cells. Mutagenesis, 22, 63–67.
   PubMed Web of Science ®Google Scholar
• Lin, W., Wei, X., Xue, H., Kelimu, M., Tao, R., Song, Y., (2000). Study on DNA strand breaks induced by sodium nitroprusside, a nitric oxide donor, in vivo and in vitro. Mutation Research, 466, 187–195.
   PubMedGoogle Scholar
• Lin, W., Xue, H., Liu, S., He, Y., Fu, J., & Zhou, Z. (1998). Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutation Research, 413, 121–127.
   PubMed Web of Science ®Google Scholar
• Nakano, T., Terato, H., Asagoshi, K., Masaoka, A., Mukuta, M., Ohyama, Y., (2003). DNA protein cross-link formation mediated by oxanine. A novel genotoxic mechanism of nitric oxide-induced DNA damage. Journal of Biological Chemistry, 278, 25264–25272.
   PubMed Web of Science ®Google Scholar
• Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., & Tannenbaum, S. R. (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences of the United States of America, 89, 3030–3034.
   PubMed Web of Science ®Google Scholar
• Okumura, F., Lenschow, D. J., & Zhang, D.-E. (2008). Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation. Journal of Biological Chemistry, 283, 24484–24488.
   PubMedGoogle Scholar
• Pederzolli, C. D., Mescka, C. P., Magnusson, A. S., Deckmann, K. B., de Souza Streck, E., & Sgaravatti, A. M. (2010). N-acetylaspartic acid impairs enzymatic antioxidant defenses and enhances hydrogen peroxide concentration in rat brain. Metabolic Brain Disease, 25, 251–259.
   PubMedGoogle Scholar
• Pederzolli, C. D., Mescka, C. P., Scapin, F., Rockenbach, F. J., Sgaravatti, A. M., Sgarbi, M. B., (2007). N-acetylaspartic acid promotes oxidative stress in cerebral cortex of rats. International Developmental Neuroscience, 25, 317–324.
   PubMedGoogle Scholar
• Rajasankar, S., Manivasagam, T., Sankar, V., Prakash, S., Muthusamy, R., Krishnamurti, A., (2009). Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. Journal of Ethnopharmacology, 125, 369–373.
   PubMedGoogle Scholar
• Richter, E., Abramova, M., & Surendran, S. (2011). Parkinson's disease: Molecular changes and therapeutic approaches. In S. Surendran (ed.), Neurochemistry of metabolic diseases, lysosomal storage diseases, phenylketonuria and Canavan disease. New York: Nova Science. Retrieved on January 14, 2011 from https://www.novapublishers.com/catalog/product_info.php?products_id=21889
   Google Scholar
• Sager, T. N., Thomsen, C., Valsborg, J. S., Laursen, H., & Hansen, A. J. (1999). Astroglia contain a specific transport mechanism for N-Acetyl-L-Aspartate. Journal of Neurochemistry, 73, 807–811.
   PubMedGoogle Scholar
• Surendran, S. (2005). Canavan disease: Genomic interaction and metabolic levels. EXCLI Journal, 4, 77–86.
   Google Scholar
• Surendran, S. (2008). N-acetyl aspartate induces nitric oxide to result neurodegeneration in Canavan disease. Bioscience Hypotheses, 1, 228–229.
   Google Scholar
• Surendran, S. (2009). Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility. Molecular Biology Reports, 36, 201–206.
   PubMedGoogle Scholar
• Surendran, S. (2010). Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease. Medical Hypotheses, 75, 533–534.
   PubMedGoogle Scholar
• Surendran, S., Bamforth, F. J., Chan, A., Tyring, S. K., Goodman, S. I., & Matalon, R. (2003). Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem. Journal of Child Neurology, 18, 809–812.
   PubMedGoogle Scholar
• Surendran, S., Kaya, N., & Ozand, P. (2011). Canavan disease: Molecular pathology, phenotype and therapeutic approaches. In S. Surendran (ed.) Neurochemistry of metabolic diseases, lysosomal storage diseases, phenylketonuria and Canavan disease. New York: Nova Science. Retrieved on January 14, 2011 from https://www.novapublishers.com/catalog/product_info.php?products_id=21889
   Google Scholar
• Surendran, S., & Kondapaka, S. (2005). Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus (LM-MP) of obesity induced diabetes mouse: Implications on enteric neurodegeneration. Biochemical and Biophysical Research Communications, 338, 919–922.
   PubMedGoogle Scholar
• Surendran, S., & Kumaresan, G. (2007). Neurochemical changes and therapeutic approaches in Canavan disease. In S. Surendran (ed.), Neurochemistry of metabolic diseases, lysosomal storage diseases, phenylketonuria and Canavan disease. Trivandrum, India: Transworld Research Network, 119–132.
   Google Scholar
• Surendran, S., Matalon, R., & Tyring, S. K. (2006). Upregulation of aspartoacylase activity in the duodenum of obesity induced diabetes mouse: Implications on diabetic neuropathy. Biochemical and Biophysical Research Communications, 345, 973–975.
   PubMedGoogle Scholar
• Surendran, S., & Rajasankar, S. (2010). Parkinson's disease: Oxidative stress and therapeutic approaches. Neurological Sciences, 31, 531–540.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., Yamada, M., Ide, H., Kanaori, K., Tajima, K., Morii, T., (2000). Identification and characterization of a reaction product of 2’-deoxyoxanosine with glycine. Chemical Research in Toxicology, 13, 227–230.
   PubMedGoogle Scholar
• Tacke, U., Olbrich, H., Sass, J. O., Fekete, A., Horvath, J., Ziyeh, S., (2005). Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease. Neuropediatrics, 36, 252–255.
   PubMedGoogle Scholar
• Taylor, D. L., Davies, S. E. C., Obrenovitch, T. P., Urenjak, J., Richards, D. A., Clark, J. B., (1994). Extracellular N-acetylaspartate in the rat brain: In vivo determination of basal levels and changes evoked by high K+. Journal of Neurochemistry, 62, 2349–2355.
   PubMedGoogle Scholar